✦ LIBER ✦

Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitro

✍ Scribed by Robert Vince; Mei Hua; Jay Brownell; Susan Daluge; Fangchen Lee; William M. Shannon; George C. Lavelle; Jeanine Qualls; Owen S. Weislow; Rebecca Kiser; Peter G. Canonico; Robert H. Schultz; V.L. Narayanan; Joseph G. Mayo; Robert H. Shoemaker; Michael R. Boyd

Book ID: 117058402
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 398 KB
Volume: 156
Category: Article
ISSN: 0006-291X
DOI: 10.1016/s0006-291x(88)80950-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carbovir: the (—) enantiomer is a potent

Carbovir: the (—) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro

✍ Jonathan A.V. Coates; Helen J. Inggall; Bridget A. Pearson; Charles R. Penn; Ric 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Potent and selective in vitro activity o

Potent and selective in vitro activity of 3' -deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus

✍ Lin Tai-Shun; Raymond F. Schinazi; William H. Prusoff 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 315 KB

ChemInform Abstract: Discovery of Imidaz

ChemInform Abstract: Discovery of Imidazo(1,2-c)pyrimidin-5(6H)-one Heterosubstituted Nucleoside Analogues with Potent Activity Against Human Hepatitis B Virus in vitro.

✍ T. S. MANSOUR; C. A. EVANS; M. CHARRON; B. E. KORBA 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

Anti-human Immunodeficiency Virus (HIV)

Anti-human Immunodeficiency Virus (HIV) agents are also potent and selective inhibitors of Feline Immunodeficiency Virus (FIV)-induced cytopathic effect: Development of a new method for screening of anti-FIV substances in vitro

✍ Akiko Tanabe-Tochikura; Tadafumi S. Tochikura; James R. Blakeslee Jr.; Richard G 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 974 KB

Potent and selective antiviral activity

Potent and selective antiviral activity of a new nucleoside analog (NSC-614846) against human immunodeficiency virus (HIV) in vitro: R. Vince, M. Hua, J. Brownell, W. M. Shannon, G.C. Lavelle, K.J. Qualls, O. Weislow, R. Kiser, R. Schultz, R.H. Shoemaker, J.G. Mayo, M.R. Boyd, and P.G. Canonico. University of Minnesota, Minneapolis, MN 55455 USA, Southern Research Institute, Birmingham, AL 35255 USA, Program Resources, Inc., Frederick, MD 21701 USA, National Cancer Institute, Bethesda, MD 20892 USA, Frederick Cancer Research Facility, NCI, Frederick, MD 21701 USA, and U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21701 USA

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 63 KB

221 In vitro anti-hepatitis B virus and

221 In vitro anti-hepatitis B virus and anti-human cytomegalovirus activities of selected 2′, 2′-difluoro purine and pyrimidine nucleoside analogs: J. M. Colacino, C. S. Grossman, K. A. Staschke, A. J. Schilke, J. S. Kroin and L. W. Hertel. Lilly Research Laboratories, Indianapolis, Indiana, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB